- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.12.25 | Criterion: Aged-care operator Ryman eyes the spoils on both sides of the Tasman | ||
| 12.12.25 | Blockbusters and quiet achievers - 12 of 2025's best Aussie wines | ||
| 12.12.25 | Closing Bell: ASX finds its groove, up 1.23pc as resources rally | ||
| 12.12.25 | Gold Digger: The bulls dominate the bears in 2026 gold outlook | ||
| 12.12.25 | Resources Top 5: HRE pumps up on scandium and yttrium as BMC flexes on debut | ||
| 12.12.25 | Scott Power: ASX healthcare awaits Christmas miracle as Immutep shines | ||
| 12.12.25 | These apps are exploding after the social media ban | ||
| 12.12.25 | Monsters of Rock: Copper, silver fly toward 2026 at all-time highs | ||
| 12.12.25 | Lunch Wrap: Gold lights the fuse again on a broad ASX rally | ||
| 12.12.25 | Ten spectacular snowy holidays | ||
| 12.12.25 | Property or shares? The No.1 investment of the past 25 years | ||
| 12.12.25 | Top 10 at 11: ASX sings on powerful gains in gold and silver overnight | ||
| 11.12.25 | Rise and Shine: Everything you need to know before the ASX opens | ||
| 11.12.25 | Unicorns Podcast: Compare Club's mission to help Australians switch and save | ||
| 11.12.25 | Long Shortz with Racura: Inside the $3.22M raise powering a lung cancer trial | ||
| 11.12.25 | Hawkish cut, dovish reality? The Fed's 2026 path is taking shape | ||
| 11.12.25 | IPO Watch: Gas explorer Macallum New Energy chases $6m IPO with prime Perth Basin acreage | ||
| 11.12.25 | Resources Top 5: Marmota rockets as Greenewood drilling uncovers eye-catching gold grades | ||
| 11.12.25 | Closing Bell: Confusion reigns after split Fed decision, but resources tick ASX higher | ||
| 11.12.25 | Self-managed superannuation slowly becomes a family affair | ||
| 11.12.25 | Papua New Guinea eyes mining revival as key developments line up | ||
| 11.12.25 | Lunch Wrap: ASX powers through the Fed fog; Marmota lights up with bonanza assays | ||
| 11.12.25 | Health Check: Argenica sharpens stroke trial strategy after AI review | ||
| 11.12.25 | Merry Christmas Neurizon as FDA clears NUZ-001 for HEALEY ALS Platform Trial | ||
| 10.12.25 | IPO Watch: Dormant assets come to market as Exultant raises $5m |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .